(Q41687092)

7 October 2017

1 reference

title

Structures of staurosporine bound to CDK2 and cAPK--new tools for structure-based design of protein kinase inhibitors (English)

1 reference

7 October 2017

0 references

Toledo LM

1

1 reference

PubMed ID

9438871

7 October 2017

Lydon NB

series ordinal

2

1 reference

PubMed ID

9438871

7 October 2017

language of work or name

1 reference

1 December 1997

1 reference

7 October 2017

1 reference

7 October 2017

5

1 reference

7 October 2017

1551-1556

1 reference

7 October 2017

12

1 reference

Signal transduction by receptors with tyrosine kinase activity

7 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Regulation of lymphocyte function by protein phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Crystal Structure of the Catalytic Subunit of Cyclic Adenosine Monophosphate-Dependent Protein Kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Three protein kinase structures define a common motif

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

The protein kinase family: conserved features and deduced phylogeny of the catalytic domains

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Domain movements in protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Staurosporine, a potentially important gift from a microorganism.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Characterization of specific binding sites for [3H]-staurosporine on various protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Staurosporine: An Effective Inhibitor for Ca2+/Calmodulin-Dependent Protein Kinase II

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Absolute Configuration of Staurosporine By X-Ray Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

2.2 A refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MnATP and a peptide inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Crystal structure of cyclin-dependent kinase 2

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Staurosporine aglycone (K252-c) and arcyriaflavin A from the marine ascidian, Eudistoma sp.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Inhibitors of protein kinase C. 1. 2,3-bisarylmaleimides

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2897%2900304-3

7 January 2021

10.1016/S0969-2126(97)00304-3

Identifiers

DOI

1 reference

7 October 2017

1 reference

PubMed ID

9438871